IntegraMed America Stock Soars (INMD)

NEW YORK ( TheStreet) -- Shares of IntegraMed America (Nasdaq: INMD) have taken a tremendous swing upward. The stock is trading at $13.71 as of 9:55 a.m. ET, 20.9% above Friday's closing price of $11.34. Volume is at 476,658, 22.5 times the daily average of 21,200.

IntegraMed America has a market cap of $134.5 million and is part of the health care sector and health services industry. Shares are up 39.1% year to date as of the close of trading on Friday.

IntegraMed America, Inc., a specialty healthcare services company, provides products and services to patients and providers in the fertility and vein care segments of healthcare industry in the United States. The company has a P/E ratio of 26.7, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates IntegraMed America as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full IntegraMed America Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.
null

If you liked this article you might like

IntegraMed America's CEO Discusses Q1 2012 Results - Earnings Call Transcript

IntegraMed's CEO Discusses Q4 2011 Results - Earnings Call Transcript

IntegraMed America's CEO Presents At Oppenheimer Healthcare Conference - Presentation Transcript

IntegraMed America's CEO Presents At Oppenheimer Healthcare Conference - Presentation Transcript

IntegraMed America Presentation At Oppenheimer Healthcare Conference - Transcript

IntegraMed America Presentation At Oppenheimer Healthcare Conference - Transcript